CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma

by Kyle B. Lupo, Sandro Matosevic
Published 2020-06-01

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy

by Kyle B. Lupo, Sandro Matosevic
Published 2019-06-01

Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

by Jiao Wang, Kyle B. Lupo, Andrea M. Chambers, Sandro Matosevic
Published 2018-12-01

Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells

by Andrea M. Chambers, Kyle B. Lupo, Sandro Matosevic, Sandro Matosevic
Published 2018-11-01

Adenosinergic Signaling Alters Natural Killer Cell Functional Responses

by Andrea M. Chambers, Jiao Wang, Kyle B. Lupo, Hao Yu, Nadia M. Atallah Lanman, Sandro Matosevic, Sandro Matosevic
Published 2018-10-01